Patents Act 1977 Sample Clauses

Patents Act 1977. 7.1 The Company and the Executive acknowledge and accepx xxx xxovisions of Sections 39 to 42 of the Patents Act 1977 ("the Act") relating to the ownership of employees' xxxxxxxxns and the compensation of employees for certain inventions respectively.
Sample 1Sample 2Sample 3See All (5)
AutoNDA by SimpleDocs
Patents Act 1977. Section 60(1)(c) Patents Act 1977 Pioneer v Warner [1997] RPC 757 BGH, GRUR 1992, 305 – “Heliumeinspeisung”; BGH, GRUR 2001, 730 – “Trigonellin”; BGH, GRUR 2014, 464 – “Kollagenese II”; OLG Karlsruhe, GRUR 2014, 764 – “Verwendungspatent”. See for example, LG Düsseldorf, 14 March 2013, 4a O 145/12 – “Ribavarin” English law Use claims, when in the form of “Use of X as …” are treated as a type of process claim. In the medical field, methods of treatment by therapy or surgery are excluded from patentability, but claims of the form “(substance X) for use in the treatment of (medical condition Y)” are permissible. Claims of this form (purpose-limited product claims) are treated as second medical use claims for the purpose of novelty and are only anticipated by a prior disclosure of the use of X for the treatment of Y. Prior to the implementation of the EPC 2000, “Swiss-form” claims (“use of X in the manufacture of a medicament for the treatment of Y”) were permitted. The Patents Court has considered the requirements for infringement of such a claim and held that the word “for” in Swiss-form claims imports a requirement of subjective intention on the part of the manufacturer that the medicament or pharmaceutical composition will be used for treating the specified condition. (NB This is a very recent decision which may be appealed.) Indirect infringement Germany Under German law a number of requirements must be fulfilled for a finding of indirect infringement: – A third party supplies or offers, within the territory of Germany, means relating to an essential element of the invention, and these means are suitable and intended to exploit the invention. – The means are offered or supplied to a person who is not entitled to exploit the patented invention. – Further, the third party must act without the consent of the patentee. – The customer intends to use the supplied means in an infringing manner. – The person offering or supplying knows or it is obvious from the circumstances that such means are suitable and intended for exploiting the invention. – The means are not staple commercial products, unless the person offering or delivering these means induces the recipient to act in a directly infringing manner.
Sample 1

Related to Patents Act 1977

  • Defend Trade Secrets Act You are hereby notified that under the Defend Trade Secrets Act: (1) no person will be held criminally or civilly liable under federal or state trade secret law for disclosure of a trade secret (as defined in the Economic Espionage Act) that is: (A) made in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and made solely for the purpose of reporting or investigating a suspected violation of law; or, (B) made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal so that it is not made public; and (2) a person who pursues a lawsuit for retaliation by an employer for reporting a suspected violation of the law may disclose the trade secret to the attorney of the person and use the trade secret information in the court proceeding, if the person files any document containing the trade secret under seal, and does not disclose the trade secret, except as permitted by court order.

  • Defend Trade Secrets Act Notice Under the U.S. Defend Trade Secrets Act of 2016, Awardee will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney, and (ii) solely for the purpose of reporting or investigating a suspected violation of law; (b) is made to Awardee’s attorney in relation to a lawsuit for retaliation against Awardee for reporting a suspected violation of law; or (c) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.

  • Employee Retirement Income Security Act of 1974 (a) Section 3.12(a) of the Disclosure Schedule sets forth a list of all Plans and Benefit Arrangements maintained by the Company and any of its Subsidiaries (which for purposes of this Section 3.12 will include any ERISA Affiliate with respect to any Plan subject to Title IV of ERISA). As to all such Plans and Benefit Arrangements, and except as disclosed in such Section 3.12(a) of the Disclosure Schedule:

  • Defend Trade Secrets Act of 2016 Influencer acknowledges receipt of the following notice under 18 U.S.C § 1833(b)(1): “An individual will not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.”

  • Foreign Corrupt Practices Act None of the Company, any of its subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company or any of its subsidiaries is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”), including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA and the Company and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith.

  • Corrupt Practices 3.1 The government requires that the bidders, suppliers, sub contractors and supervisors observe the highest standards of ethics during the execution of such contracts. In this pursuit of this policy, the government; Defines for the purpose of this provision, the terms set forth below as follows:

  • Xxxxxx Act Any provisions required to be contained in this Agreement by Section 126 and/or Section 130-k or Article 4-A of the New York Real Property Law are hereby incorporated herein, and such provisions shall be in addition to those conferred or imposed by this Agreement; provided, however, that to the extent that such Section 126 and/or 130-k shall not have any effect, and if said Section 126 and/or Section 130-k should at any time be repealed or cease to apply to this Agreement or be construed by judicial decision to be inapplicable, said Section 126 and/or Section 130-k shall cease to have any further effect upon the provisions of this Agreement. In a case of a conflict between the provisions of this Agreement and any mandatory provisions of Article 4-A of the New York Real Property Law, such mandatory provisions of said Article 4-A shall prevail, provided that if said Article 4-A shall not apply to this Agreement, should at any time be repealed, or cease to apply to this Agreement or be construed by judicial decision to be inapplicable, such mandatory provisions of such Article 4-A shall cease to have any further effect upon the provisions of this Agreement.

  • Competition Act The aggregate value of all assets in Canada that are owned by the Company and by corporations controlled by the Company (other than assets that are shares of any of those corporations) or the annual gross revenues from sales in and from Canada generated from such assets do not exceed, in either case $50 million as determined pursuant to subsection 110(3) of the Competition Act. 69 QuickLinks

  • CONTRACTS (RIGHTS OF THIRD PARTIES) ACT 1999 A person who is not a party to this Agreement will not have any right under the Contracts (Rights of Third Parties) Act 1999 to enforce any of its terms but this will not affect any right or remedy of a third party which exists or is available apart from that Act.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!